drugset / Trial / NCT01309854

Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects

NCT01309854

Phase 1 Completed 15 enrolled AstraZeneca
Non-randomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to investigate the drug interaction between fostamatinib and pioglitazone by comparing the safety, tolerability and plasma concentration of pioglitazone when administered alone and with fostamatinib in healthy subjects.

Timeline

Start
2011-03
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fostamatinib Small molecule 100 mg Oral
Subject Pioglitazone Small molecule 30 mg Oral

Indications